logo
Sign in

BSYI Stock Price, Chart, Stats & News

BioSyntech, Inc.
Save

BioSyntech, Inc. (BSYI) does not currently pay a dividend.

229,033
Market cap
–
Current P/E
–
Forward P/E

BSYI chart

Price history is unavailable

We don't have enough price data for BSYI to draw a chart yet.

About

Health care
Sector
Biotechnology
Industry

BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing chronic wounds; BST-Ossifil, used in bone void filling; BST-Ossifix, which provides structural support for bones; and BST-Disc, focused on restoring intervertebral discs. Beyond these, BioSyntech offers injectable products leveraging BST-Gel technology to precisely deliver biotherapeutics.

Similar securities

Based on sector and market capitalization

Report issue